nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—rheumatoid arthritis—psoriatic arthritis	0.876	1	CtDrD
Penicillamine—SLCO1B1—Methotrexate—psoriatic arthritis	0.0157	1	CbGbCtD
Penicillamine—Aplasia pure red cell—Auranofin—psoriatic arthritis	0.00755	0.0699	CcSEcCtD
Penicillamine—Nephrotic syndrome—Auranofin—psoriatic arthritis	0.00257	0.0237	CcSEcCtD
Penicillamine—Interstitial pneumonia—Auranofin—psoriatic arthritis	0.00257	0.0237	CcSEcCtD
Penicillamine—Interstitial lung disease—Auranofin—psoriatic arthritis	0.00175	0.0162	CcSEcCtD
Penicillamine—Guillain-Barre syndrome—Methotrexate—psoriatic arthritis	0.00165	0.0153	CcSEcCtD
Penicillamine—Proteinuria—Auranofin—psoriatic arthritis	0.00141	0.0131	CcSEcCtD
Penicillamine—Protein urine present—Auranofin—psoriatic arthritis	0.00139	0.0129	CcSEcCtD
Penicillamine—Glossitis—Auranofin—psoriatic arthritis	0.00135	0.0125	CcSEcCtD
Penicillamine—Myasthenia gravis—Dexamethasone—psoriatic arthritis	0.00122	0.0113	CcSEcCtD
Penicillamine—Myasthenia gravis—Betamethasone—psoriatic arthritis	0.00122	0.0113	CcSEcCtD
Penicillamine—Atrophy—Prednisolone—psoriatic arthritis	0.00121	0.0112	CcSEcCtD
Penicillamine—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00116	0.0108	CcSEcCtD
Penicillamine—Atrophy—Triamcinolone—psoriatic arthritis	0.00112	0.0103	CcSEcCtD
Penicillamine—Atrophy—Methylprednisolone—psoriatic arthritis	0.00111	0.0103	CcSEcCtD
Penicillamine—Atrophy—Dexamethasone—psoriatic arthritis	0.00101	0.00937	CcSEcCtD
Penicillamine—Atrophy—Betamethasone—psoriatic arthritis	0.00101	0.00937	CcSEcCtD
Penicillamine—Lupus erythematosus—Triamcinolone—psoriatic arthritis	0.000976	0.00903	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.000954	0.00883	CcSEcCtD
Penicillamine—Alveolitis allergic—Methotrexate—psoriatic arthritis	0.00092	0.00851	CcSEcCtD
Penicillamine—Leukaemia—Methotrexate—psoriatic arthritis	0.000891	0.00825	CcSEcCtD
Penicillamine—Atrophy—Prednisone—psoriatic arthritis	0.000881	0.00816	CcSEcCtD
Penicillamine—Trauma—Prednisolone—psoriatic arthritis	0.00083	0.00768	CcSEcCtD
Penicillamine—Eosinophilia—Auranofin—psoriatic arthritis	0.00077	0.00713	CcSEcCtD
Penicillamine—Trauma—Triamcinolone—psoriatic arthritis	0.000763	0.00707	CcSEcCtD
Penicillamine—Trauma—Methylprednisolone—psoriatic arthritis	0.000762	0.00705	CcSEcCtD
Penicillamine—Pancytopenia—Auranofin—psoriatic arthritis	0.000739	0.00684	CcSEcCtD
Penicillamine—Trauma—Betamethasone—psoriatic arthritis	0.000693	0.00641	CcSEcCtD
Penicillamine—Trauma—Dexamethasone—psoriatic arthritis	0.000693	0.00641	CcSEcCtD
Penicillamine—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00068	0.00629	CcSEcCtD
Penicillamine—Stomatitis—Auranofin—psoriatic arthritis	0.000676	0.00626	CcSEcCtD
Penicillamine—Haematuria—Auranofin—psoriatic arthritis	0.000661	0.00612	CcSEcCtD
Penicillamine—Systemic lupus erythematosus—Triamcinolone—psoriatic arthritis	0.000657	0.00608	CcSEcCtD
Penicillamine—Agranulocytosis—Auranofin—psoriatic arthritis	0.000647	0.00599	CcSEcCtD
Penicillamine—Optic neuritis—Prednisolone—psoriatic arthritis	0.000643	0.00595	CcSEcCtD
Penicillamine—Trauma—Prednisone—psoriatic arthritis	0.000603	0.00558	CcSEcCtD
Penicillamine—Peptic ulcer—Prednisolone—psoriatic arthritis	0.000591	0.00547	CcSEcCtD
Penicillamine—Optic neuritis—Triamcinolone—psoriatic arthritis	0.000591	0.00547	CcSEcCtD
Penicillamine—Optic neuritis—Methylprednisolone—psoriatic arthritis	0.00059	0.00546	CcSEcCtD
Penicillamine—Alopecia—Auranofin—psoriatic arthritis	0.00055	0.00509	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Methotrexate—psoriatic arthritis	0.000546	0.00505	CcSEcCtD
Penicillamine—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.000544	0.00503	CcSEcCtD
Penicillamine—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.000543	0.00502	CcSEcCtD
Penicillamine—Optic neuritis—Dexamethasone—psoriatic arthritis	0.000536	0.00496	CcSEcCtD
Penicillamine—Optic neuritis—Betamethasone—psoriatic arthritis	0.000536	0.00496	CcSEcCtD
Penicillamine—Dysgeusia—Auranofin—psoriatic arthritis	0.000531	0.00491	CcSEcCtD
Penicillamine—Anaemia—Auranofin—psoriatic arthritis	0.000501	0.00464	CcSEcCtD
Penicillamine—Interstitial pneumonia—Methotrexate—psoriatic arthritis	0.000497	0.0046	CcSEcCtD
Penicillamine—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.000493	0.00457	CcSEcCtD
Penicillamine—Peptic ulcer—Betamethasone—psoriatic arthritis	0.000493	0.00457	CcSEcCtD
Penicillamine—Leukopenia—Auranofin—psoriatic arthritis	0.000485	0.00449	CcSEcCtD
Penicillamine—Appetite absent—Methotrexate—psoriatic arthritis	0.000482	0.00447	CcSEcCtD
Penicillamine—Optic neuritis—Prednisone—psoriatic arthritis	0.000467	0.00432	CcSEcCtD
Penicillamine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.000433	0.00401	CcSEcCtD
Penicillamine—Rash erythematous—Dexamethasone—psoriatic arthritis	0.000431	0.00399	CcSEcCtD
Penicillamine—Rash erythematous—Betamethasone—psoriatic arthritis	0.000431	0.00399	CcSEcCtD
Penicillamine—Peptic ulcer—Prednisone—psoriatic arthritis	0.00043	0.00398	CcSEcCtD
Penicillamine—Anorexia—Auranofin—psoriatic arthritis	0.000422	0.0039	CcSEcCtD
Penicillamine—Vasculitis—Prednisolone—psoriatic arthritis	0.000405	0.00375	CcSEcCtD
Penicillamine—Eruption—Methotrexate—psoriatic arthritis	0.00039	0.00361	CcSEcCtD
Penicillamine—Leukocytosis—Methylprednisolone—psoriatic arthritis	0.000386	0.00357	CcSEcCtD
Penicillamine—Decreased appetite—Auranofin—psoriatic arthritis	0.000384	0.00356	CcSEcCtD
Penicillamine—Extravasation—Dexamethasone—psoriatic arthritis	0.000378	0.0035	CcSEcCtD
Penicillamine—Extravasation—Betamethasone—psoriatic arthritis	0.000378	0.0035	CcSEcCtD
Penicillamine—Vasculitis—Triamcinolone—psoriatic arthritis	0.000372	0.00345	CcSEcCtD
Penicillamine—Vasculitis—Methylprednisolone—psoriatic arthritis	0.000372	0.00344	CcSEcCtD
Penicillamine—Neuropathy—Prednisolone—psoriatic arthritis	0.000371	0.00343	CcSEcCtD
Penicillamine—Bone marrow depression—Methotrexate—psoriatic arthritis	0.000356	0.00329	CcSEcCtD
Penicillamine—Urticaria—Auranofin—psoriatic arthritis	0.000351	0.00325	CcSEcCtD
Penicillamine—Leukocytosis—Dexamethasone—psoriatic arthritis	0.000351	0.00325	CcSEcCtD
Penicillamine—Leukocytosis—Betamethasone—psoriatic arthritis	0.000351	0.00325	CcSEcCtD
Penicillamine—Neuropathy—Triamcinolone—psoriatic arthritis	0.000341	0.00316	CcSEcCtD
Penicillamine—Neuropathy—Methylprednisolone—psoriatic arthritis	0.000341	0.00315	CcSEcCtD
Penicillamine—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.000339	0.00314	CcSEcCtD
Penicillamine—Vasculitis—Dexamethasone—psoriatic arthritis	0.000338	0.00313	CcSEcCtD
Penicillamine—Vasculitis—Betamethasone—psoriatic arthritis	0.000338	0.00313	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.000331	0.00307	CcSEcCtD
Penicillamine—Injury—Prednisolone—psoriatic arthritis	0.000312	0.00289	CcSEcCtD
Penicillamine—Neuropathy—Betamethasone—psoriatic arthritis	0.00031	0.00287	CcSEcCtD
Penicillamine—Neuropathy—Dexamethasone—psoriatic arthritis	0.00031	0.00287	CcSEcCtD
Penicillamine—Leukocytosis—Prednisone—psoriatic arthritis	0.000306	0.00283	CcSEcCtD
Penicillamine—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.000305	0.00282	CcSEcCtD
Penicillamine—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.000304	0.00281	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.000303	0.0028	CcSEcCtD
Penicillamine—Diarrhoea—Auranofin—psoriatic arthritis	0.000303	0.0028	CcSEcCtD
Penicillamine—Vasculitis—Prednisone—psoriatic arthritis	0.000294	0.00272	CcSEcCtD
Penicillamine—Injury—Triamcinolone—psoriatic arthritis	0.000287	0.00266	CcSEcCtD
Penicillamine—Injury—Methylprednisolone—psoriatic arthritis	0.000286	0.00265	CcSEcCtD
Penicillamine—Vomiting—Auranofin—psoriatic arthritis	0.000281	0.0026	CcSEcCtD
Penicillamine—Rash—Auranofin—psoriatic arthritis	0.000279	0.00258	CcSEcCtD
Penicillamine—Dermatitis—Auranofin—psoriatic arthritis	0.000279	0.00258	CcSEcCtD
Penicillamine—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.000277	0.00256	CcSEcCtD
Penicillamine—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.000277	0.00256	CcSEcCtD
Penicillamine—Extravasation—Methotrexate—psoriatic arthritis	0.000275	0.00255	CcSEcCtD
Penicillamine—Proteinuria—Methotrexate—psoriatic arthritis	0.000273	0.00253	CcSEcCtD
Penicillamine—Neuropathy—Prednisone—psoriatic arthritis	0.00027	0.0025	CcSEcCtD
Penicillamine—Protein urine present—Methotrexate—psoriatic arthritis	0.000269	0.00249	CcSEcCtD
Penicillamine—Nausea—Auranofin—psoriatic arthritis	0.000263	0.00243	CcSEcCtD
Penicillamine—Glossitis—Methotrexate—psoriatic arthritis	0.00026	0.00241	CcSEcCtD
Penicillamine—Injury—Dexamethasone—psoriatic arthritis	0.00026	0.00241	CcSEcCtD
Penicillamine—Injury—Betamethasone—psoriatic arthritis	0.00026	0.00241	CcSEcCtD
Penicillamine—Muscular weakness—Prednisolone—psoriatic arthritis	0.000253	0.00234	CcSEcCtD
Penicillamine—Vasculitis—Methotrexate—psoriatic arthritis	0.000246	0.00228	CcSEcCtD
Penicillamine—Pancreatitis—Prednisolone—psoriatic arthritis	0.000243	0.00225	CcSEcCtD
Penicillamine—Thrombophlebitis—Prednisone—psoriatic arthritis	0.000241	0.00223	CcSEcCtD
Penicillamine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.000233	0.00215	CcSEcCtD
Penicillamine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.000232	0.00215	CcSEcCtD
Penicillamine—Asthma—Triamcinolone—psoriatic arthritis	0.000228	0.00211	CcSEcCtD
Penicillamine—Injury—Prednisone—psoriatic arthritis	0.000227	0.0021	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000225	0.00209	CcSEcCtD
Penicillamine—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000224	0.00207	CcSEcCtD
Penicillamine—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000223	0.00206	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—psoriatic arthritis	0.000217	0.00201	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000217	0.00201	CcSEcCtD
Penicillamine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000211	0.00195	CcSEcCtD
Penicillamine—Muscular weakness—Betamethasone—psoriatic arthritis	0.000211	0.00195	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—psoriatic arthritis	0.000204	0.00189	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000201	0.00186	CcSEcCtD
Penicillamine—Haemoglobin—Prednisolone—psoriatic arthritis	0.0002	0.00185	CcSEcCtD
Penicillamine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000199	0.00184	CcSEcCtD
Penicillamine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000199	0.00184	CcSEcCtD
Penicillamine—Haemorrhage—Prednisolone—psoriatic arthritis	0.000198	0.00184	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—psoriatic arthritis	0.000194	0.00179	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000185	0.00171	CcSEcCtD
Penicillamine—Muscular weakness—Prednisone—psoriatic arthritis	0.000184	0.0017	CcSEcCtD
Penicillamine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000183	0.0017	CcSEcCtD
Penicillamine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000183	0.00169	CcSEcCtD
Penicillamine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000183	0.00169	CcSEcCtD
Penicillamine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000182	0.00169	CcSEcCtD
Penicillamine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000181	0.00167	CcSEcCtD
Penicillamine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000181	0.00167	CcSEcCtD
Penicillamine—Pancreatitis—Prednisone—psoriatic arthritis	0.000177	0.00164	CcSEcCtD
Penicillamine—Haemoglobin—Betamethasone—psoriatic arthritis	0.000166	0.00154	CcSEcCtD
Penicillamine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000166	0.00154	CcSEcCtD
Penicillamine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000166	0.00153	CcSEcCtD
Penicillamine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000166	0.00153	CcSEcCtD
Penicillamine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000165	0.00153	CcSEcCtD
Penicillamine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00016	0.00148	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000157	0.00146	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000157	0.00145	CcSEcCtD
Penicillamine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000156	0.00144	CcSEcCtD
Penicillamine—Asthma—Methotrexate—psoriatic arthritis	0.000151	0.00139	CcSEcCtD
Penicillamine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00015	0.00139	CcSEcCtD
Penicillamine—Angiopathy—Betamethasone—psoriatic arthritis	0.00015	0.00139	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—psoriatic arthritis	0.000149	0.00138	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—psoriatic arthritis	0.000148	0.00137	CcSEcCtD
Penicillamine—Alopecia—Betamethasone—psoriatic arthritis	0.000146	0.00135	CcSEcCtD
Penicillamine—Alopecia—Dexamethasone—psoriatic arthritis	0.000146	0.00135	CcSEcCtD
Penicillamine—Haemoglobin—Prednisone—psoriatic arthritis	0.000145	0.00134	CcSEcCtD
Penicillamine—Haemorrhage—Prednisone—psoriatic arthritis	0.000144	0.00134	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000143	0.00132	CcSEcCtD
Penicillamine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000135	0.00125	CcSEcCtD
Penicillamine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000135	0.00125	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000134	0.00124	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—psoriatic arthritis	0.000132	0.00122	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—psoriatic arthritis	0.000131	0.00121	CcSEcCtD
Penicillamine—Angiopathy—Prednisone—psoriatic arthritis	0.000131	0.00121	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—psoriatic arthritis	0.000128	0.00119	CcSEcCtD
Penicillamine—Alopecia—Prednisone—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Penicillamine—Mental disorder—Prednisone—psoriatic arthritis	0.000126	0.00117	CcSEcCtD
Penicillamine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000126	0.00116	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000125	0.00116	CcSEcCtD
Penicillamine—Anxiety—Dexamethasone—psoriatic arthritis	0.000122	0.00113	CcSEcCtD
Penicillamine—Anxiety—Betamethasone—psoriatic arthritis	0.000122	0.00113	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000121	0.00112	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000121	0.00112	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000119	0.0011	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000118	0.00109	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000118	0.00109	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000118	0.00109	CcSEcCtD
Penicillamine—Anaemia—Prednisone—psoriatic arthritis	0.000116	0.00107	CcSEcCtD
Penicillamine—Agitation—Prednisone—psoriatic arthritis	0.000115	0.00107	CcSEcCtD
Penicillamine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000115	0.00107	CcSEcCtD
Penicillamine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000115	0.00107	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—psoriatic arthritis	0.000112	0.00104	CcSEcCtD
Penicillamine—Anorexia—Betamethasone—psoriatic arthritis	0.000112	0.00104	CcSEcCtD
Penicillamine—Anorexia—Dexamethasone—psoriatic arthritis	0.000112	0.00104	CcSEcCtD
Penicillamine—Urticaria—Prednisolone—psoriatic arthritis	0.000112	0.00104	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—psoriatic arthritis	0.000109	0.00101	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000107	0.000992	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000107	0.000992	CcSEcCtD
Penicillamine—Arthralgia—Prednisone—psoriatic arthritis	0.000107	0.000989	CcSEcCtD
Penicillamine—Anxiety—Prednisone—psoriatic arthritis	0.000107	0.000986	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—psoriatic arthritis	0.000107	0.000986	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000106	0.000983	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—psoriatic arthritis	0.000106	0.000977	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000104	0.000962	CcSEcCtD
Penicillamine—Urticaria—Triamcinolone—psoriatic arthritis	0.000103	0.000954	CcSEcCtD
Penicillamine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000103	0.000951	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000103	0.000951	CcSEcCtD
Penicillamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000103	0.000949	CcSEcCtD
Penicillamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000102	0.000947	CcSEcCtD
Penicillamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000102	0.000947	CcSEcCtD
Penicillamine—Skin disorder—Prednisone—psoriatic arthritis	9.95e-05	0.000921	CcSEcCtD
Penicillamine—Anorexia—Prednisone—psoriatic arthritis	9.77e-05	0.000904	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—psoriatic arthritis	9.7e-05	0.000898	CcSEcCtD
Penicillamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	9.55e-05	0.000884	CcSEcCtD
Penicillamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	9.53e-05	0.000882	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—psoriatic arthritis	9.39e-05	0.000869	CcSEcCtD
Penicillamine—Urticaria—Betamethasone—psoriatic arthritis	9.35e-05	0.000865	CcSEcCtD
Penicillamine—Urticaria—Dexamethasone—psoriatic arthritis	9.35e-05	0.000865	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	9.34e-05	0.000864	CcSEcCtD
Penicillamine—Body temperature increased—Dexamethasone—psoriatic arthritis	9.3e-05	0.000861	CcSEcCtD
Penicillamine—Body temperature increased—Betamethasone—psoriatic arthritis	9.3e-05	0.000861	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—psoriatic arthritis	8.93e-05	0.000827	CcSEcCtD
Penicillamine—Decreased appetite—Prednisone—psoriatic arthritis	8.91e-05	0.000825	CcSEcCtD
Penicillamine—Rash—Prednisolone—psoriatic arthritis	8.89e-05	0.000823	CcSEcCtD
Penicillamine—Dermatitis—Prednisolone—psoriatic arthritis	8.88e-05	0.000822	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	8.87e-05	0.000821	CcSEcCtD
Penicillamine—Diarrhoea—Methylprednisolone—psoriatic arthritis	8.85e-05	0.000819	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—psoriatic arthritis	8.39e-05	0.000776	CcSEcCtD
Penicillamine—Nausea—Prednisolone—psoriatic arthritis	8.38e-05	0.000775	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—psoriatic arthritis	8.32e-05	0.00077	CcSEcCtD
Penicillamine—Vomiting—Triamcinolone—psoriatic arthritis	8.25e-05	0.000763	CcSEcCtD
Penicillamine—Vomiting—Methylprednisolone—psoriatic arthritis	8.23e-05	0.000761	CcSEcCtD
Penicillamine—Rash—Triamcinolone—psoriatic arthritis	8.18e-05	0.000757	CcSEcCtD
Penicillamine—Dermatitis—Triamcinolone—psoriatic arthritis	8.17e-05	0.000756	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—psoriatic arthritis	8.16e-05	0.000756	CcSEcCtD
Penicillamine—Rash—Methylprednisolone—psoriatic arthritis	8.16e-05	0.000755	CcSEcCtD
Penicillamine—Dermatitis—Methylprednisolone—psoriatic arthritis	8.15e-05	0.000754	CcSEcCtD
Penicillamine—Urticaria—Prednisone—psoriatic arthritis	8.14e-05	0.000754	CcSEcCtD
Penicillamine—Body temperature increased—Prednisone—psoriatic arthritis	8.1e-05	0.00075	CcSEcCtD
Penicillamine—Diarrhoea—Dexamethasone—psoriatic arthritis	8.05e-05	0.000745	CcSEcCtD
Penicillamine—Diarrhoea—Betamethasone—psoriatic arthritis	8.05e-05	0.000745	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	7.8e-05	0.000722	CcSEcCtD
Penicillamine—Nausea—Triamcinolone—psoriatic arthritis	7.7e-05	0.000713	CcSEcCtD
Penicillamine—Nausea—Methylprednisolone—psoriatic arthritis	7.69e-05	0.000711	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisone—psoriatic arthritis	7.55e-05	0.000699	CcSEcCtD
Penicillamine—Vomiting—Dexamethasone—psoriatic arthritis	7.48e-05	0.000692	CcSEcCtD
Penicillamine—Vomiting—Betamethasone—psoriatic arthritis	7.48e-05	0.000692	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—psoriatic arthritis	7.44e-05	0.000689	CcSEcCtD
Penicillamine—Rash—Dexamethasone—psoriatic arthritis	7.42e-05	0.000687	CcSEcCtD
Penicillamine—Rash—Betamethasone—psoriatic arthritis	7.42e-05	0.000687	CcSEcCtD
Penicillamine—Dermatitis—Dexamethasone—psoriatic arthritis	7.41e-05	0.000686	CcSEcCtD
Penicillamine—Dermatitis—Betamethasone—psoriatic arthritis	7.41e-05	0.000686	CcSEcCtD
Penicillamine—Diarrhoea—Prednisone—psoriatic arthritis	7.01e-05	0.000649	CcSEcCtD
Penicillamine—Nausea—Betamethasone—psoriatic arthritis	6.99e-05	0.000647	CcSEcCtD
Penicillamine—Nausea—Dexamethasone—psoriatic arthritis	6.99e-05	0.000647	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—psoriatic arthritis	6.8e-05	0.00063	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—psoriatic arthritis	6.77e-05	0.000627	CcSEcCtD
Penicillamine—Vomiting—Prednisone—psoriatic arthritis	6.52e-05	0.000603	CcSEcCtD
Penicillamine—Rash—Prednisone—psoriatic arthritis	6.46e-05	0.000598	CcSEcCtD
Penicillamine—Dermatitis—Prednisone—psoriatic arthritis	6.46e-05	0.000597	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—psoriatic arthritis	6.31e-05	0.000584	CcSEcCtD
Penicillamine—Nausea—Prednisone—psoriatic arthritis	6.09e-05	0.000563	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—psoriatic arthritis	5.86e-05	0.000542	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—psoriatic arthritis	5.45e-05	0.000504	CcSEcCtD
Penicillamine—Rash—Methotrexate—psoriatic arthritis	5.4e-05	0.0005	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—psoriatic arthritis	5.39e-05	0.000499	CcSEcCtD
Penicillamine—Nausea—Methotrexate—psoriatic arthritis	5.09e-05	0.000471	CcSEcCtD
